Carboplatin/Ipilimumab/Nivolumab/Paclitaxel Regimen

Preferred Label : Carboplatin/Ipilimumab/Nivolumab/Paclitaxel Regimen;

NCIt synonyms : Carboplatin/Paclitaxel Plus Ipilimumab/Nivolumab; Nivolumab Plus Ipilimumab Plus Paclitaxel/Carboplatin; Carboplatin-Ipilimumab-Nivolumab-Paclitaxel; Carboplatin-Ipilimumab-Nivolumab-Paclitaxel Regimen; Carboplatin/Ipilimumab/Nivolumab/Paclitaxel; Carboplatin/Yervoy/Opdivo/Paclitaxel; Nivolumab/Ipilimumab/Pacliitaxel/Carboplatin;

NCIt related terms : Carboplatin and Paclitaxel (CP) and Ipilimumab, Nivolumab;

NCIt definition : A regimen consisting of carboplatin, ipilimumab, nivolumab and paclitaxel that can be used for the treatment of non-small cell lung cancer (NSCLC).;

NCI Metathesaurus CUI : CL1778430;

Codes from synonyms : 2822;

Details

Origin ID

C185947;

UMLS CUI

C5670179;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Carboplatin [NCIt concept]
- Ipilimumab [NCIt concept]
- Nivolumab [NCIt concept]
- Paclitaxel [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients